Staff Publications: March 2017

  1. Arvold ND, Pinnell NE, Mahadevan A, et al. Steroid and Anticonvulsant Prophylaxis for Stereotactic Radiosurgery: Large Variation in Physician Recommendations. Practical radiation oncology. 2016;6(4):e89-96. PMID: 26850650.
  2. Baker N, Tong C, Simhan J. Reconstructive Management Options of Delayed Complications Following Bladder Outlet Surgery. Current urology reports. 2017;18(4):27. PMID: 28247326.
  3. Bartel MJ, Raimondo M. Endoscopic Management of Pancreatic Cysts. Digestive diseases and sciences. 2017. PMID: 28315030.
  4. Bazzoli A, Karanicolas J. “Solvent Hydrogen-Bond Occlusion”: A New Model of Polar Desolvation for Biomolecular Energetics. Journal of computational chemistry. 2017. PMID: 28318014.
  5. Berger ER, Wang CE, Kaufman CS, et al. National Accreditation Program for Breast Centers Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality Measure. Journal of the American College of Surgeons. 2017;224(3):236-244.
  6. Bingham C, Fernandez SV, Fittipaldi P, et al. Mutational Studies on Single Circulating Tumor Cells Isolated from the Blood of Inflammatory Breast Cancer Patients. Breast cancer research and treatment. 2017. PMID: 28271309.
  7. Campbell SC, Dong W, Uzzo R, Kutikov A. Re: Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. European urology. 2017;71(3):495-495.
  8. Dong Y, Ruth KJ, Churilla TM, et al. The Need for Androgen Deprivation Therapy in Patients with Intermediate-Risk Prostate Cancer Treated with Dose-Escalated External Beam Radiation Therapy. The Canadian journal of urology. 2017;24(1):8656-8662. PMID: 28263132.
  9. Escudier B, Sharma P, McDermott DF, et al. Checkmate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma. European urology. 2017. PMID: 28262413.
  10. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. Cancer. 2016;122(9):1349-1369. PMID: 26799932.
  11. Gaponova AV, Deneka AY, Beck TN, et al. Identification of Evolutionarily Conserved DNA Damage Response Genes That Alter Sensitivity to Cisplatin. Oncotarget. 2017;8(12):19156-19171.
  12. Geynisman DM, de Velasco G, Sewell KL, Jacobs I. Biosimilar Biologic Drugs: A New Frontier in Medical Care. Postgraduate medicine. 2017. PMID: 28343424.
  13. Grove M, Kim H, Santerre M, et al. Yap/Taz Initiate and Maintain Schwann Cell Myelination. Elife. 2017;6. PMID: 28124973. PMC5287714.
  14. Haas NB, Manola J, Dutcher JP, et al. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the Assure Randomized Trial. JAMA oncology. 2017. PMID: 28278333.
  15. Haifler M, Kutikov A. Update on Renal Mass Biopsy. Current urology reports. 2017;18(4):28. PMID: 28251484.
  16. Hensley H, Cooper HS, Chang WL, Clapper ML. Imaging Matrix Metalloproteases in Spontaneous Colon Tumors: Validation by Correlation with Histopathology. Methods in molecular biology (Clifton, NJ). 2017;1579:245-255. PMID: 28299741.
  17. Huang Q, He S, Tian Y, et al. Hsp90 Inhibition Destabilizes Ezh2 Protein in Alloreactive T Cells and Reduces Graft-Versus-Host Disease in Mice. Blood. 2017. PMID: 28246193.
  18. Hurwitz MD, Harris J, Sartor O, et al. Adjuvant Radiation Therapy, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of Nrg Oncology/Rtog Study 0621. Cancer. 2017. PMID: 28323339.
  19. Kennedy AS, Ball D, Cohen SJ, et al. Baseline Hemoglobin and Liver Function Predict Tolerability and Overall Survival of Patients Receiving Radioembolization for Chemotherapy-Refractory Metastatic Colorectal Cancer. Journal of gastrointestinal oncology. 2017;8(1):70-80. PMID: 28280611. PMC5334043.
  20. Kennedy PT, Bertoletti A, Mason WS. Reply. Gastroenterology. 2017;152(5):1246-1247. PMID: 28273438.
  21. Korobeynikov V, Deneka AY, Golemis EA. Mechanisms for Nonmitotic Activation of Aurora-a at Cilia. Biochemical Society Transactions. 2017;45(1):37-39. PMID:
  22. Lawler AC, Ghiraldi EM, Tong C, Friedlander JI. Extracorporeal Shock Wave Therapy: Current Perspectives and Future Directions. Current urology reports. 2017;18(4):25. PMID: 28247327.
  23. Leroy B, Ballinger ML, Baran-Marszak F, et al. Recommended Guidelines for Validation, Quality Control, and Reporting of Tp53 Variants in Clinical Practice. Cancer research. 2017;77(6):1250-1260. PMID: 28254861.
  24. Liu HL, Huang BY, Zhang MS, Wang HR, Qu YM, Yu CJ. Sellar and Suprasellar Granular Cell Tumor of Neurohypophysis. Chinese medical journal. 2017;130(6):741-743. PMID: 28303860.
  25. LoRusso PM, Infante JR, Kim KB, et al. A Phase I Dose-Escalation Study of Selumetinib in Combination with Docetaxel or Dacarbazine in Patients with Advanced Solid Tumors. BMC cancer. 2017;17(1):173. PMID: 28264648. PMC5340007.
  26. Lynch SM, Mitra N, Ross M, et al. A Neighborhood-Wide Association Study (Nwas): Example of Prostate Cancer Aggressiveness. PloS one. 2017;12(3):e0174548. PMID: 28346484.
  27. Merza H, Bilusic M. Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions. Current oncology reports. 2017;19(4):27. PMID: 28303494.
  28. Mullinax JE, Kroon HM, Thompson JF, et al. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. J Am Coll Surg. 2017;224(4):635-642. PMID: 28214556.
  29. Mustian KM, Alfano CM, Heckler C, et al. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-Analysis. JAMA oncology. 2017. PMID: 28253393.
  30. Naito S, Makhov P, Astsaturov I, et al. Ldl Cholesterol Counteracts the Antitumour Effect of Tyrosine Kinase Inhibitors against Renal Cell Carcinoma. British journal of cancer. 2017. PMID: 28350788.
  31. Necchi A, Pond GR, Raggi D, et al. Clinical Outcomes of Perioperative Chemotherapy in Patients with Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis. Clinical genitourinary cancer. 2017. PMID: 28325636.
  32. Peri S, Caretti E, Tricarico R, et al. Haploinsufficiency in Tumor Predisposition Syndromes: Altered Genomic Transcription in Morphologically Normal Cells Heterozygous for Vhl or Tsc Mutation. Oncotarget. 2017;8(11):17628-17642.
  33. Phelan CM, Kuchenbaecker KB, Tyrer JP, et al. Identification of 12 New Susceptibility Loci for Different Histotypes of Epithelial Ovarian Cancer. Nature genetics. 2017. PMID: 28346442.
  34. Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: Us-Blacks, Haitians, and Jamaicans. Cancer control : journal of the Moffitt Cancer Center. 2016;23(4):347-358. PMID: 27842324. PMC5321133.
  35. Pollack A, Kwon D, Walker G, et al. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated with Radiotherapy for Prostate Cancer. Jnci-Journal of the National Cancer Institute. 2017;109(2). PMID: WOS:000396774100009.
  36. Prabhu VV, Hong B, Allen JE, et al. Small-Molecule Prodigiosin Restores P53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells Via C-Jun-Mediated Deltanp73 Inhibition and P73 Activation. Cancer research. 2016;76(7):1989-1999. PMID: 26759239.
  37. Raynal NJ, Da Costa EM, Lee JT, et al. Repositioning Fda-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome. Molecular cancer therapeutics. 2017;16(2):397-407. PMID: 27980103. PMC5292054.
  38. Rimm DL, Han G, Taube JM, et al. A Prospective, Multi-Institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for Pd-L1 Expression in Non-Small Cell Lung Cancer. JAMA oncology. 2017. PMID: 28278348.
  39. Ristau BT, Smaldone MC. Kidney Cancer: Emerging Guidelines for Managing Small Renal Masses. Nature reviews Urology. 2017. PMID: 28290457.
  40. Schootman M, Gomez SL, Henry KA, et al. Geospatial Approaches to Cancer Control and Population Sciences. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017. PMID: 28325736.
  41. Schrock AB, Li SD, Frampton GM, et al. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017. PMID: 28315738.
  42. Stein MN, Bertino JR, Kaufman HL, et al. First-in-Human Clinical Trial of Oral Onc201 in Patients with Refractory Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017. PMID: 28331050.
  43. Stroup AM, Herget KA, Hanson HA, et al. Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood. Cancer Epidemiology Biomarkers & Prevention. 2017;26(1):75-84.
  44. Tokar JJ, Warrick JW, Guckenberger DJ, et al. Interrogating Bronchoalveolar Lavage Samples Via Exclusion-Based Analyte Extraction. SLAS technology. 2017:2472630317696780. PMID: 28298147.
  45. Traino HM, Siminoff LA. Keep It Going: Maintaining Health Conversations Using Relational and Instrumental Approaches. Health communication. 2016;31(3):308-319. PMID: 26325602.
  46. van Vulpen M, Wang L. Within the Next Five Years, Adaptive Hypofractionation Will Become the Most Common Form of Radiotherapy. Medical physics. 2016;43(7):3941. PMID: 27370112.
  47. Volokh OI, Derkacheva NI, Studitsky VM, Sokolova OS. [Structural Studies of Chromatin Remodeling Factors]. Molekuliarnaia biologiia. 2016;50(6):922-934. PMID: 28064308.
  48. Wang Y, Santerre M, Tempera I, Martin K, Mukerjee R, Sawaya BE. Hiv-1 Vpr Disrupts Mitochondria Axonal Transport and Accelerates Neuronal Aging. Neuropharmacology. 2017;117:364-375. PMID: 28212984.
  49. Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW. Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: An Institutional Experience. Endocrine pathology. 2016;27(4):359-362. PMID: 27379493.
  50. Wierda WG, Zelenetz AD, Gordon LI, et al. Nccn Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(3):293-311. PMID: 28275031.
  51. Wiest DL. Themis-Tery Is Solved. Nature immunology. 2017;18(4):368-370. PMID: 28323266.
  52. Yoon SM, Shaikh T, Hallman M. Therapeutic Management Options for Stage Iii Non-Small Cell Lung Cancer. World journal of clinical oncology. 2017;8(1):1-20. PMID: 28246582. PMC5309711.
  53. Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB. Astro Apex(R) and Ro-Ils Are Applicable to Medical Malpractice in Radiation Oncology. Future oncology (London, England). 2016;12(22):2643-2657. PMID: 27470145.
  54. Zaorsky NG, Showalter TN, Ezzell GA, et al. Acr Appropriateness Criteria® External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer, Part I of Ii. Advances in Radiation Oncology. 2017;2(1):62-84.
  55. Zawistowski JS, Bevill SM, Goulet DR, et al. Enhancer Remodeling During Adaptive Bypass to Mek Inhibition Is Attenuated by Pharmacologic Targeting of the P-Tefb Complex. Cancer discovery. 2017;7(3):302-321. PMID: 28108460. PMC5340640.
  56. Zhang FF, Haslam DE, Terry MB, et al. Dietary Isoflavone Intake and All-Cause Mortality in Breast Cancer Survivors: The Breast Cancer Family Registry. Cancer. 2017. PMID: 28263368.
  57. Zijoo R, von Mehren M. Efficacy of Trabectedin for the Treatment of Liposarcoma. Expert opinion on pharmacotherapy. 2016;17(14):1953-1962. PMID: 27615729.

Staff Publications: February 2017

1.    van Esterik JC, Vitins AP, Hodemaekers HM, et al. Liver DNA Methylation Analysis in Adult Female C57bl/6jxfvb Mice Following Perinatal Exposure to Bisphenol A. Toxicology Letters. 2015;232(1):293-300. PMID: 25455458.

2.    Conn KM, Fisher SG, Rhee H. Parent and Child Independent Report of Emotional Responses to Asthma-Specific Vignettes: The Relationship between Emotional States, Self-Management Behaviors, and Symptoms. Journal of Pediatric Nursing. 2016;31(2):e83-90. PMID: 26711704.

3.    Koshkareva Y, Liu JC, Lango M, Galloway T, Gaughan JP, Ridge JA. Cervical Metastasis in Squamous Cell Carcinoma of the Hard Palate and Maxillary Alveolus. Ear, Nose and Throat Journal. 2016;95(10-11):E6.

4.    Zuniga S, Ebersole B, Jamal N. Inpatient Injection Laryngoplasty for Vocal Fold Immobility: When Is It Really Necessary? American Journal of Otolaryngology – Head and Neck Medicine and Surgery. 2016.

5.    Abbosh P, Sundararajan S, Millis SZ, et al. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer. European Urology Focus. 2017.

6.    Biermann JS, Chow W, Reed DR, et al. Nccn Guidelines Insights: Bone Cancer, Version 2.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(2):155-167. PMID: 28188186.

7.    Burstein HJ, Krilov L, Aragon-Ching JB, et al. Clinical Cancer Advances 2017: Annual Report on Progress against Cancer from the American Society of Clinical Oncology. Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology. 2017:Jco2016715292. PMID: 28148207.

8.    Chang WL, Masih S, Thadi A, et al. Plecanatide-Mediated Activation of Guanylate Cyclase-C Suppresses Inflammation-Induced Colorectal Carcinogenesis in Apc+/Min-Fccc Mice. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017;8(1):47-59. PMID: 28217374. PMC5292606.

9.    Chernoff J. Alfred G. Knudson Jr, Md, Phd: In Memoriam (1922-2016). Cancer Research. 2017;77(4):815-816. PMID: 28202462.

10.    Christian AH, O’Malley D, Barac A, Miller SM, Hudson SV. Cardiovascular Risk and Communication among Early Stage Breast Cancer Survivors. Patient Education and Counseling. 2017. PMID: 28215826.

11.    Darlow SD, Heckman CJ, Munshi T, Collins BN. Thirdhand Smoke Beliefs and Behaviors among Healthcare Professionals. Psychology, Health & Medicine. 2017;22(4):415-424.

12.    Daugherty M, Sedaghatpour D, Shapiro O, Vourganti S, Kutikov A, Bratslavsky G. The Metastatic Potential of Renal Tumors: Influence of Histologic Subtypes on Definition of Small Renal Masses, Risk Stratification, and Future Active Surveillance Protocols. Urologic Oncology. 2017. PMID: 28202224.

13.    Ghatalia P, Zibelman M, Geynisman DM, Plimack ER. Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. Current Treatment Options in Oncology. 2017;18(1):7. PMID: 28210995.

14.    Goldfinger LE, Michael JV. Regulation of Ras Signaling and Function by Plasma Membrane Microdomains. Bioscience Trends. 2017. PMID: 28179601.

15.    Greenberg PL, Stone RM, Al-Kali A, et al. Myelodysplastic Syndromes, Version 2.2017 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2017;15(1):60-87.

16.    Hamdi Y, Soucy P, Kuchenbaeker KB, et al. Association of Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers with Genetic Variants Showing Differential Allelic Expression: Identification of a Modifier of Breast Cancer Risk at Locus 11q22.3. Breast Cancer Research and Treatment. 2017;161(1):117-134.

17.    Heckman CJ, Handorf E, Darlow SD, Yaroch AL, Raivitch S. Refinement of Measures to Assess Psychosocial Constructs Associated with Skin Cancer Risk and Protective Behaviors of Young Adults. Journal of Behavioral Medicine. 2017. PMID: 28155000.

18.    Heinrich M, Rankin C, Blanke CD, et al. Correlation of Long-Term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 Swog Intergroup Trial S0033. JAMA Oncology. 2017. PMID: 28196207.

19.    Joshi S, Kutikov A. Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment Editorial Comment. Journal of Urology. 2017;197(2):383-384.

20.    Joshi SS, Chen DYT. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin Editorial Comment. Journal of Urology. 2017;197(2):307-307.

21.    Kayser K, Acquati C, Reese JB, Mark K, Wittmann D, Karam E. A Systematic Review of Dyadic Studies Examining Relationship Quality in Couples Facing Colorectal Cancer Together. Psycho-Oncology. 2017:No Pagination Specified.

22.    Khayati K, Antikainen H, Bonder EM, et al. The Amino Acid Metabolite Homocysteine Activates Mtorc1 to Inhibit Autophagy and Form Abnormal Proteins in Human Neurons and Mice. FASEB Journal : official publication of the Federation of American Societies for Experimental Biology. 2017;31(2):598-609. PMID: 28148781.

23.    Koh WJ, Greer BE, Abu-Rustum NR, et al. Vulvar Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2017;15(1):92-120.

24.    Koller SE, Bauer KW, Egleston BL, et al. Comparative Effectiveness and Risks of Bowel Preparation before Elective Colorectal Surgery. Annals of Surgery. 2017.

25.    Kudinov AE, Karanicolas J, Golemis EA, Boumber Y. Musashi Rna-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2017. PMID: 28143872.

26.    Lilge L, Terry MB, Walter J, et al. Non-Invasive Optical Spectroscopic Monitoring of Breast Development During Puberty. Breast Cancer Research : BCR. 2017;19(1):12. PMID: 28166807. PMC5294901.

27.    Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF. Role of Radical Prostatectomy in Metastatic Prostate Cancer: A Review. Urologic Oncology. 2017. PMID: 28190749.

28.    Miller KD, Rall GF. What Kaplan-Meier Survival Curves Don’t Tell Us About Cns Disease. Journal of Neuroimmunology. 2017. PMID: 28187911.

29.    Miller SM, Tagai EK, Wen KY, et al. Predictors of Adherence to Follow-up Recommendations after an Abnormal Pap Smear among Underserved Inner-City Women. Patient Education and Counseling. 2017. PMID: 28190541.

30.    Mullinax JE, Kroon HM, Thompson JF, et al. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. Journal of the American College of Surgeons. 2017. PMID: 28214556.

31.    Ng C, Zhang Z, Lee SI, et al. Ct Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An Acrin and Gog Study. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2017. PMID: 28174234.

32.    Orcutt KD, Adams GP, Wu AM, et al. Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging. Molecular Imaging and Biology : MIB : the official publication of the Academy of Molecular Imaging. 2017. PMID: 28213834.

33.    Pang JH, Patel SA, King SA, Curcillo PG, 2nd, Weiss ES, Buchanan DR. Reduced-Port Approach to Laparoscopic Flap Harvest (Ralfh): An Anterior Sheath Sparing Rectus Abdominis Flap. Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS. 2017. PMID: 28238721.

34.    Prinsep MR, Appleton TG, Hanson GR, et al. Tolyporphin Macrocycles from the Cyanobacterium Tolypothrix Nodosa Selectively Bind Copper and Silver and Reverse Multidrug Resistance. Inorganic Chemistry. 2017. PMID: 28240882.

35.    Prouet P, Giri S, Wiedower E, et al. Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-Dlbcl without Increasing Early Mortality. Anticancer Research. 2017;37(2):813-817. PMID: 28179335.

36.    Sato T, Issa JJ, Kropf P. DNA Hypomethylating Drugs in Cancer Therapy. Cold Spring Harbor Perspectives in Medicine. 2017. PMID: 28159832.

37.    Schuetze KB, Stratton MS, Blakeslee WW, et al. Overlapping and Divergent Actions of Structurally Distinct Hdac Inhibitors in Cardiac Fibroblasts. The Journal of Pharmacology and Experimental Therapeutics. 2017. PMID: 28174211.

38.    Semenova G, Chernoff J. Targeting Pak1. Biochemical Society Transactions. 2017;45(1):79-88. PMID: 28202661.

39.    Shaikh T, Li T, Handorf EA, et al. Long-Term Patient-Reported Outcomes from a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology, biology, physics. 2017;97(4):722-731. PMID: 28244407.

40.    Skates SJ, Greene MH, Buys SS, et al. Early Detection of Ovarian Cancer Using the Risk of Ovarian Cancer Algorithm with Frequent Ca125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2017. PMID: 28143870.

41.    Teye EK, Sido A, Xin P, et al. Pign Gene Expression Aberration Is Associated with Genomic Instability and Leukemic Progression in Acute Myeloid Leukemia with Myelodysplastic Features. Oncotarget. 2017. PMID: 28187452.

42.    Waingankar N, Mallin K, Smaldone M, et al. Assessing the Relative Influence of Hospital and Surgeon Volume on Short-Term Mortality Following Radical Cystectomy. BJU International. 2017. PMID: 28192632.

43.    Weldon CB, Madenci AL, Boikos SA, et al. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report from the National Institutes of Health Pediatric and Wildtype Gist Clinic. Journal of Clinical Oncology. 2017;35(5):523-528.

44.    Zaorsky NG, Williams GR, Barta SK, et al. Splenic Irradiation for Splenomegaly: A Systematic Review. Cancer Treatment Reviews. 2017;53:47-52. PMID: 28063304.

EndNote’s NIH Output Style Helps You with the new NIH Bibliography Format

We have been getting phone calls of late regarding changes to the NIH bibliography format. As of March 2016, “anyone submitting an application, proposal or report to the NIH must include the PMC reference number (PMCID) when citing applicable papers that they author or that arise from their NIH-funded research.” The other requirement is that all authors of a given article be listed in the bibliographic citation. If you have EndNote, you can kill both birds with one stone.

Back in 2014, the NIH created an EndNote output style called NIH (Grant Format). In this style, all of the authors are included and the PMID and PMCID are added automatically. To see if the NIH format is included in your version of EndNote:

  1. In EndNote for Windows, click on the Bibliographic Output Style drop-down arrow located in the EndNote toolbar.
  2. Check the list provided and click NIH, if it appears.

The drop-down list of output styles is an alphabetical list of your most heavily-used styles. If you do not see NIH on that list, proceed as follows:

  1. In EndNote for Windows, click on the Bibliographic Output Style drop-down arrow located in the EndNote toolbar.
  2. Click Select Another Style.
  3. Output styles are arranged alphabetically by name. Scroll down to and click NIH if it appears on the list.
  4. Click Choose.

If you do not see NIH in the Choose a Style box, it may be installed just not visible:

  1. In EndNote for Windows, click Edit, then click Output Styles, and then click Open Style Manager.
  2. In the EndNote Styles box, scroll down to and select the NIH checkbox.
  3. Close the EndNote Styles box.

If you do not see NIH in the EndNote Styles box, it may not be installed and proceed as follows:

  1. Google EndNote downloads.
  2. Click Downloads | EndNote | Clarivate Analytics
  3. Scroll down to and click Add output styles.
  4. In the text box located directly under the Publisher drop-down list, type NIH.
  5. Click NIH (Grant Format).
  6. Click Download this Style.
  7. In the Opening NIH.ens box, make sure that Open with is selected and EndNote X8 (or X7) appears as the default.
    If you do not see EndNote, click the down arrow then click Other, click EndNote, and then click OK.
  8. Click OK.
  9. In EndNote, click File and then click Save As.
  10. In the Style Name text box, delete Copy if it appears.
  11. Click Save.

If your article has been submitted to PMC by the publisher and does not have a PMCID yet use “PMC Journal – In Process”. If either the publisher, the author, or the author’s designee has submitted the manuscript using the NIHMS, provide a valid NIH Manuscript Submission System reference number (NIHMSID) until the PMCID becomes available. Whatever method of deposit you use, be sure to add the PMCID when it becomes available. If your article was accepted for publication before the NIH Public Access Policy went into effect, then no special notation is required.

For more information about when to include the PMCID see, NIH Public Access Policy Include PMCID in Citation.

Staff Publications – January 2017

1.    Afifi M, Deiab N, El-Farrash A, et al. Su-F-T-281: Monte Carlo Investigation of Sources of Dosimetric Discrepancies with 2d Arrays. Medical physics. 2016;43(6):3527. PMID: 28047911.
2.    Al Ashkar E, Eldib A, Eraba K, Imam M, Ma C. Su-F-T-79: Monte Carlo Investigation of Optimizing Parameters for Modulated Electron Arc Therapy. Medical physics. 2016;43(6):3479. PMID: 28048738.
3.    Andersen CL, Sikora MJ, Boisen MM, et al. Active Estrogen Receptor-Alpha Signaling in Ovarian Cancer Models and Clinical Specimens. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017. PMID: 28073843.
4.    Ariazi EA, Taylor JC, Black MA, et al. A New Role for Eralpha: Silencing Via DNA Methylation of Basal, Stem Cell, and Emt Genes. Molecular cancer research : MCR. 2016. PMID: 28108626.
5.    Bodson J, Ding Q, Warner EL, Hawkins AJ, Henry KA, Kepka D. Sub-Regional Assessment of Hpv Vaccination among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities. Maternal and child health journal. 2017. PMID: 28092058.
6.    Burns KE, Hensley H, Robinson MK, Thevenin D. Therapeutic Efficacy of a Family of Phlip-Mmaf Conjugates in Cancer Cells and Mouse Models. Molecular pharmaceutics. 2017. PMID: 28048942.
7.    Buys SS, Sandbach JF, Gammon A, et al. A Study of over 35,000 Women with Breast Cancer Tested with a 25-Gene Panel of Hereditary Cancer Genes. Cancer. 2017. PMID: 28085182.
8.    Carrer A, Parris JL, Trefely S, et al. Impact of High Fat Diet on Tissue Acyl-Coa and Histone Acetylation Levels. The Journal of biological chemistry. 2017. PMID: 28077572.
9.    Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. We-Ab-Bra-02: Study of the Therapeutic Effects of Pulsed Focused Ultrasound Combined with Encapsulated Chemotherapeutic Agents for Prostate Cancer in Vivo. Medical physics. 2016;43(6):3791. PMID: 28048451.
10.    Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. Su-F-J-225: Histology Study of Mr Guided Pulsed Focused Ultrasound on Treatment of Prostate Cancer in Vivo. Medical physics. 2016;43(6):3460-3461. PMID: 28046739.
11.    Chibani O, Fan J, Tahanout F, Eldib A, Ma C. Su-F-T-375: Optimization of a New Co-60 Machine for Intensity Modulated Radiation Therapy: A Monte Carlo Characterization Study. Medical physics. 2016;43(6):3549. PMID: 28047825.
12.    Chibani O, Tahanout F, Ma C. Tu-Ab-Brc-04: Commissioning of a New Mlc Model for the Gepts Monte Carlo System: A Model Based on the Leaf and Interleaf Effective Density. Medical physics. 2016;43(6):3730. PMID: 28048146.
13.    Cornell RF, D’Souza A, Kassim AA, et al. Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 2017;23(2):269-277.
14.    Costa LJ, Maddocks K, Epperla N, et al. Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies. American Journal of Hematology. 2017;92(2):161-170.
15.    Cvetkovic D, Wang B, Gupta R, Ma C. Su-F-T-674: In Vitro Study of 5-Aminolevulinic Acid-Mediated Photo Dynamic Therapy in Human Cancer Cell Lines. Medical physics. 2016;43(6):3619. PMID: 28048178.
16.    Deer TR, Pope JE, Hayek SM, et al. The Polyanalgesic Consensus Conference (Pacc): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks. Neuromodulation : journal of the International Neuromodulation Society. 2017. PMID: 28042914.
17.    Eldib A, Chibani O, Chen L, Li J, Price R, Ma C. Su-F-T-524: Investigation of the Dosimertric Benefits of Interchangeable Source Size of a Novel Rotating Gamma System. Medical physics. 2016;43(6):3583-3584. PMID: 28047166.
18.    Eldib A, Chibani O, Mora G, et al. Su-F-T-649: Dosimetric Evaluation of Non-Coplanar Arc Therapy Using a Novel Rotating Gamma Ray System. Medical physics. 2016;43(6):3613. PMID: 28046237.
19.    Fan J, Lin T, Jin L, et al. Mo-Fg-Campus-Jep3-05: Evaluation of 4d Ct-on-Rails Target Localization Methods for Free Breathing Liver Stereotactic Body Radiotherapy (Sbrt). Medical physics. 2016;43(6):3727. PMID: 28047328.
20.    Finelli A, Ismaila N, Bro B, et al. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017:Jco2016699645. PMID: 28095147.
21.    Franco-Barraza J, Francescone R, Luong T, et al. Matrix-Regulated Integrin Alphavbeta5 Maintains Alpha5beta1-Dependent Desmoplastic Traits Prognostic of Neoplastic Recurrence. eLife. 2017;6. PMID: 28139197.
22.    George E, Kim H, Krepler C, et al. A Patient-Derived-Xenograft Platform to Study Brca-Deficient Ovarian Cancers. JCI insight. 2017;2(1):e89760. PMID: 28097235. PMC5214535.
23.    Gross S, Kotova EY, Maluchenko NV, Pascal JM, Studitsky VM. Evaluating Parp1 Domains as Gossypol Targets. Moscow University Biological Sciences Bulletin. 2016;71(4):235-239.
24.    Gupta R, Cvetkovic D, Wang B, Chen L, Ma C. We-Ab-Bra-01: Biodistribution of Paclitaxel-Loaded Nanodroplets for Prostate Cancer Management Using Ultrasound-Mediated Drug Delivery under Mrguidance. Medical physics. 2016;43(6):3791. PMID: 28046379.
25.    Gupta R, Eldib A, Li J, Ma C. Su-F-T-610: Comparison of Output Factors for Small Radiation Fields Used in Sbrt Treatment. Medical physics. 2016;43(6):3604. PMID: 28047767.
26.    Hayakawa K, Formica AM, Brill-Dashoff J, et al. Early Generated B1 B Cells with Restricted Bcrs Become Chronic Lymphocytic Leukemia with Continued C-Myc and Low Bmf Expression. Journal of Experimental Medicine. 2016;213(13):3007-3023.
27.    Huang JF, Zhang FZ, Zou QZ, et al. Induction Chemotherapy Followed by Concurrent Chemoradiation and Nimotuzumab for Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results from a Phase Ii Clinical Trial. Oncotarget. 2017;8(2):2457-2465.
28.    Infante JR, Patnaik A, Verschraegen CF, et al. Two Phase 1 Dose-Escalation Studies Exploring Multiple Regimens of Litronesib (Ly2523355), an Eg5 Inhibitor, in Patients with Advanced Cancer. Cancer chemotherapy and pharmacology. 2017. PMID: 28097385.
29.    Jin L, Fan J, Eldib A, Price R, Ma C. Su-F-T-81: Treating Nose Skin Using Energy and Intensity Modulated Electron Beams with Monte Carlo Based Dose Calculation. Medical physics. 2016;43(6):3480. PMID: 28047422.
30.    John EM, Terry MB, Keegan TH, et al. The Legacy Girls Study: Growth and Development in the Context of Breast Cancer Family History. Epidemiology (Cambridge, Mass). 2016;27(3):438-448. PMID: 26829160.
31.    Kang J, Zhang S, Philbrook S, Paul S, Wang B. Su-F-T-416: Dosimetric Comparison of Coplanar and Non-Coplanar Imrt Plans for Peripheral Lung Lesion. Medical physics. 2016;43(6):3558-3559. PMID: 28047745.
32.    Kelly AD, Kroeger H, Yamazaki J, et al. A Cpg Island Methylator Phenotype in Acute Myeloid Leukemia Independent of Idh Mutations and Associated with a Favorable Outcome. Leukemia. 2017. PMID: 28074068.
33.    Kutikov A, Uzzo RG, Smaldone MC, Haifler M, Bratslavsky G, Leibovich BC. Reply to Patrick O. Richard, Micheal as Jewett and Antonio Finelli’s Letter to the Editor Re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol. In Press. Http://Dx.Doi.Org/10.1016/J.Eururo.2016.04.001. European Urology. 2017;71(2):E47-E48.
34. HO, Wang LQ, Kuo YM, et al. Lack of Global Epigenetic Methylation Defects in Cbs Deficient Mice. Journal of Inherited Metabolic Disease. 2017;40(1):113-120.
35.    Lin T, Ma C. Su-F-J-117: Impact of Motion Artifacts on Image Quality and Accuracy of Tumor Motion Reconstruction in 4d Ct-on-Rails and Mv-Cbct Scans: A Phantom Study. Medical physics. 2016;43(6):3433-3434. PMID: 28048240.
36.    Lin T, Wang L, Galloway T, Ma C. Su-F-J-13: Choosing an Imrt Technique in the Treatment of Head and Neck Cancer with Daily Localization Uncertainties. Medical physics. 2016;43(6):3408. PMID: 28047351.
37.    Litwin S, Basickes S, Ross EA. Two-Sample Binary Phase 2 Trials with Low Type I Error and Low Sample Size. Statistics in medicine. 2017. PMID: 28118686.
38.    Liu J, Eldib A, Lin M, Li J, Mora G, Ma C. Su-G-Brc-08: Evaluation of Dose Mass Histogram as a More Representative Dose Description Method Than Dose Volume Histogram in Lung Cancer Patients. Medical physics. 2016;43(6):3628. PMID: 28047740.
39.    Lydiatt WM, Patel SG, O’Sullivan B, et al. Head and Neck Cancers-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA: a cancer journal for clinicians. 2017. PMID: 28128848.
40.    Ma C, Chibani O, Eldib A, Li J, Chen L. Su-F-T-529: Dosimetric Investigation of a Rotating Gamma Ray System for Imagedguided Modulated Arc Radiotherapy. Medical physics. 2016;43(6):3584-3585. PMID: 28048393.
41.    Ma C, Wang B, Cvetkovic D, Chen L. Su-F-J-216: Mr-Guided Non-Thermal Pulsed Focused Ultrasound for Cancer Therapy. Medical physics. 2016;43(6):3458. PMID: 28048114.
42.    Ma GX, Fang CY, Seals B, et al. A Community-Based Randomized Trial of Hepatitis B Screening among High-Risk Vietnamese Americans. American journal of public health. 2017:e1-e8. PMID: 28103075.
43.    Manne SL, Virtue SM, Ozga M, et al. A Comparison of Two Psychological Interventions for Newly-Diagnosed Gynecological Cancer Patients. Gynecologic Oncology. 2017;144(2):354-362.
44.    Mesa R, Jamieson C, Bhatia R, et al. Myeloproliferative Neoplasms, Version 2.2017. Journal of the National Comprehensive Cancer Network. 2016;14(12):1572-1611.
45.    Minervini A, Campi R, Sessa F, et al. Positive Surgical Margins and Local Recurrence after Simple Enucleation and Standard Partial Nephrectomy for Malignant Renal Tumors: Systematic Review of the Literature and Meta-Analysis of Prevalence. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2017. PMID: 28124871.
46.    Mirhadi AJ, Zhang Q, Hanks GE, et al. Effect of Long-Term Hormonal Therapy (Vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on Nrg Oncology Rtog 9202. International journal of radiation oncology, biology, physics. 2017;97(3):511-515. PMID: 28126300.
47.    Mookerjee-Basu J, Kappes DJ. Inkt Cells Do a Fat Lot of Good. Nature Immunology. 2017;18(1):10-12.
48.    O’Malley D, Dewan AA, Ohman-Strickland P, Gundersen DA, Miller SM, Hudson SV. Determinants of Patient Activation in a Community Sample of Breast and Prostate Cancer Survivors. Psycho-oncology. 2017. PMID: 28133892.
49.    Plimack ER, Bellmunt J, Gupta S, et al. Safety and Activity of Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Cancer (Keynote-012): A Non-Randomised, Open-Label, Phase 1b Study. The Lancet Oncology. 2017. PMID: 28081914.
50.    Price R, Veltchev I, Lin T, Gleason R, Ma C. Su-F-T-345: Quasi-Dead Beams: Clinical Relevance and Implications for Automatic Planning. Medical physics. 2016;43(6):3542. PMID: 28048497.
51.    Ristau BT, Smaldone MC. Radical Prostatectomy in Metastatic Prostate Cancer: Is There Enough Evidence? Vertical Bar Opinion: No. International Braz J Urol. 2016;42(5):880-882.
52.    Roy I, Boyle KA, Vonderhaar EP, et al. Cancer Cell Chemokines Direct Chemotaxis of Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma. Laboratory investigation; a journal of technical methods and pathology. 2017. PMID: 28092365.
53.    Seabloom DE, Galbraith AR, Haynes AM, et al. Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention. Cancer prevention research (Philadelphia, Pa). 2017. PMID: 28052934.
54.    Semenova G, Stepanova D, Deyev SM, Chernoff J. Medium Throughput Biochemical Compound Screening Identifies Novel Agents for Pharmacotherapy of Neurofibromatosis Type I. Biochimie. 2017. PMID: 28065690.
55.    Shapiro GI, Vaishampayan UN, LoRusso P, et al. First-in-Human Trial of an Anti-5t4 Antibody-Monomethylauristatin Conjugate, Pf-06263507, in Patients with Advanced Solid Tumors. Investigational new drugs. 2017. PMID: 28070718.
56.    Sharma P, Retz M, Siefker-Radtke A, et al. Nivolumab in Metastatic Urothelial Carcinoma after Platinum Therapy (Checkmate 275): A Multicentre, Single-Arm, Phase 2 Trial. The Lancet Oncology. 2017. PMID: 28131785.
57.    Skalka AM, Andrake MD, Katz RA. Successes and Challenges with Retroviral Enzymes. Postepy biochemii. 2016;62(3):280-285. PMID: 28132482.
58.    Soni RS, Ebersole B, Jamal N. Treatment of Chronic Cough. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2017;156(1):103-108. PMID: 28045638.
59.    Stroup AM, Herget KA, Hanson HA, et al. Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood. Cancer Epidemiology Biomarkers and Prevention. 2017;26(1):75-84.
60.    Tan Y, Sementino E, Xu J, et al. The Homeoprotein Dlx5 Drives Murine T-Cell Lymphomagenesis by Directly Transactivating Notch and Upregulating Akt Signaling. Oncotarget. 2017. PMID: 28122332.
61.    Tonisen F, Perrin L, Bayarmagnai B, van den Dries K, Cambi A, Gligorijevic B. Ep4 Receptor Promotes Invadopodia and Invasion in Human Breast Cancer. European journal of cell biology. 2017. PMID: 28094049.
62.    Valieva ME, Gerasimova NS, Kudryashova KS, et al. Stabilization of Nucleosomes by Histone Tails and by Fact Revealed by Spfret Microscopy. Cancers. 2017;9(1). PMID: 28067802.
63.    Veltchev I, Price R, Anderson P, Ma C. Su-F-T-07: Dosimetric Impact of the Dwell Position Inaccuracy in Hdr Ring and Tandem Treatments with Varisourceix Afterloader. Medical physics. 2016;43(6):3462-3463. PMID: 28048740.
64.    Veltchev I, Price R, Horwitz E, Ma C. Su-F-T-34: Transition Form Ct-Based to Ultrasound-Based Hdr Treatment Planning for Prostate Cancer. Medical physics. 2016;43(6):3469. PMID: 28047569.
65.    Waingankar N, Bratslavsky G, Jimenez C, Russo P, Kutikov A. Pheochromocytoma in Urologic Practice. European urology focus. 2016;1(3):231-240. PMID: 28078330. PMC5222610.
66.    Wang B, He W, Cvetkovic D, Chen L, Fan J, Ma C. Su-G-Iep4-11: Monitoring Tumor Growth in Subcutaneous Murine Tumor Model in Vivo: A Comparison between Mri and Small Animal Ct. Medical physics. 2016;43(6):3680. PMID: 28047612.
67.    Wang B, He W, Cvetkovic D, Chen L, Ma C. Su-F-J-215: Non-Thermal Pulsed High Intensity Focused Ultrasound Therapy Combined with 5-Aminolevulinic Acid: An in Vivo Pilot Study. Medical physics. 2016;43(6):3458. PMID: 28048774.
68.    Wang HH, Zaorsky NG, Meng MB, et al. Stereotactic Radiation Therapy for Oligometastases or Oligorecurrence within Mediastinal Lymph Nodes. Oncotarget. 2016;7(14):18135-18145. PMID: 26919113. PMC4951277.
69.    Weitzner BD, Jeliazkov JR, Lyskov S, et al. Modeling and Docking of Antibody Structures with Rosetta. Nature protocols. 2017;12(2):401-416. PMID: 28125104.
70.    Williams SB, Huo J, Chamie K, et al. Discerning the Survival Advantage among Patients with Prostate Cancer Who Undergo Radical Prostatectomy or Radiotherapy: The Limitations of Cancer Registry Data. Cancer. 2017. PMID: 28099688.
71.    Zaorsky NG, Williams GR, Barta SK, et al. Splenic Irradiation for Splenomegaly: A Systematic Review. Cancer treatment reviews. 2016;53:47-52. PMID: 28063304.
72.    Zhang Q, Sun QY, Xiao GP, et al. We-Fg-Bra-12: Research Work of the Radio-Dynamic Treatment Mechanism. Medical physics. 2016;43(6):3826. PMID: 28047568.
73.    Zhang Y, O’Leary MN, Peri S, et al. Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-Mrna Splicing. Cell reports. 2017;18(2):545-556. PMID: 28076796. PMC5234864.
74.    Zuniga S, Ebersole B, Jamal N. Inpatient Injection Laryngoplasty for Vocal Fold Immobility: When Is It Really Necessary? American journal of otolaryngology. 2017. PMID: 28131551.

EndNote X8 is Here

EndNote X8 is available for download on Machias. For more information about installing EndNote X8 please phone us at (215) 728-2711 or consult our EndNote Libguide. EndNote is not difficult to install yourself, but it is a two-step process. First, you need to install the installer and then you install the program. If you have an earlier version of EndNote installed please create backup copies of your libraries and then uninstall whatever version you have before installing X8.

Here is what’s new in EndNote X8

  1. Share your library with up to 100 other EndNote desktop users on X7.2 or later; providing teams with immediate real time access to the same set of references, attachments, notes and annotations.
  2. Access the Activity Feed to see what your colleagues are doing in the Shared Library and when new members join.
  3. New, modern, easy to identify icons – identical across both Mac and Windows.
  4. Updated workflows for finding reference updates.
  5. Every X8 library includes a built in Recently Added group which can be customized, allowing users to pick up right where they left off in the research workflow.
  6. Configure Sync option in the Groups pane to simplify desktop activation process.
  7. Utilize unlimited file attachment storage in your online library.
  8. Cite While You Write for Microsoft Word 2016.

We at the library are being trained on some of the new features including the improved sharing features. We will be sharing our knowledge with you.